Congleton Jon Insider Trades & Stock Holdings

Chief Executive Officer · Mineralys Therapeutics, Inc. · Latest filing Sep 30, 2026

Congleton Jon, Chief Executive Officer at Mineralys Therapeutics, Inc. has 1 Form 4 trade on file since Sep 30, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.91M), net -$1.91M. Latest filing: disposed of 75K shares of $MLYS on Sep 30, 2026 at $25.46.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.91M

Net open-market

-$1.91M

Latest filing

Sep 30, 2026

All insider trades by Congleton Jon

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 30, 2026	$MLYS	Sell (Open-market sale) 10b5-1	75K	$25.46	$1.91M			-12.1%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Congleton Jon traded

• $MLYS

Frequently asked questions

Has Congleton Jon been buying or selling stock?

Congleton Jon has 0 open-market purchases and 1 open-market sale on file, net -$1.91M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Congleton Jon's latest insider trade?

disposed of 75K shares of $MLYS on Sep 30, 2026 at $25.46.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.